Panel Discussion: Building a General Consensus on Model Selection Criteria Across Oncology Drug Development

• Understanding the different tumour models used in drug discovery and development across the field
• Exploring the various questions and contexts of use for each main model type and how translatable and clinically relevant they truly are
• How did you overcome hurdles encountered with your model when trying to better understand your drug/target?

Speakers:

Rocio Evangelista Vaz

Director, Head of Preclinical Pharmacology

Molecular Partners AG

Lene Trinh

Research Scientist

CataVax

Maria Melander

Principal Research Scientist

Servier Symphogen